World's Best Scientists 2026 revealed!
Maurizio D'Incalci

Maurizio D'Incalci

D-Index & Metrics

Medicine

D-Index
91
Citations
30065
World Ranking
11763
National Ranking
439

Maurizio D'Incalci publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Maurizio D'Incalci sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 703 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Maurizio D'Incalci D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Maurizio D'Incalci sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Maurizio D'Incalci is affiliated with Humanitas University in Italy. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with a notable emphasis on molecular biology, cancer research, pulmonary and respiratory medicine, oncology, and reproductive medicine.

The main topics addressed in their research include:

  • Ovarian cancer diagnosis and treatment
  • Cancer genomics and diagnostics
  • Occupational and environmental lung diseases
  • Cancer-related molecular mechanisms research
  • PARP inhibition in cancer therapy
  • Sarcoma diagnosis and treatment
  • Cancer research and treatments

Recent publications by D'Incalci include:

  • "High-dose vitamin C enhances cancer immunotherapy," 2020, Science Translational Medicine
  • "European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer," 2021, Annals of Oncology
  • "DNA Damage Response and Immune Defense," 2020, International Journal of Molecular Sciences
  • "Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma," 2021, Frontiers in Oncology
  • "Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma," 2021, Theranostics

Frequent co-authors collaborating with D'Incalci encompass:

  • Sergio Marchini
  • Laura Mannarino
  • Lara Paracchini
  • Roberta Frapolli
  • Luca Beltrame

The scientist's work has appeared repeatedly in several publication venues, including:

  • Zenodo (CERN European Organization for Nuclear Research)
  • Cancer Research
  • Cancers
  • Frontiers in Oncology
  • ESMO Open

Best Publications

  • Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

    Giovanni Germano;Roberta Frapolli;Cristina Belgiovine;Achille Anselmo

  • Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

    Giovanni Germano;Simona Lamba;Giuseppe Rospo;Ludovic Barault

  • Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

    Federica Grosso;Robin L. Jones;George D. Demetri;Ian R. Judson

  • A Review of Trabectedin (ET-743): A Unique Mechanism of Action

    Maurizio D'Incalci;Carlos M. Galmarini

  • Role of α1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL+ Leukemic Cells to the Abl Inhibitor STI571

    Carlo Gambacorti-Passerini;Rossella Barni;Philipp le Coutre;Massimo Zucchetti

  • Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action.

    E Erba;D Bergamaschi;L Bassano;G Damia

  • Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin) : Inhibition of macrophage differentiation and cytokine production

    Paola Allavena;Mauro Signorelli;Marcello Chieppa;Eugenio Erba

  • Apoptosis Biochemical events and relevance to cancer chemotherapy

    Soumitra Sen;Maurizio D'Incalci

  • Limbic seizures induce P-glycoprotein in rodent brain: Functional implications for pharmacoresistance

    Massimo Rizzi;Silvio Caccia;Giovanna Guiso;Cristina Richichi

  • Bortezomib-induced peripheral neurotoxicity : A neurophysiological and pathological study in the rat

    Guido Cavaletti;Alessandra Gilardini;Annalisa Canta;Laura Rigamonti

  • Distribution Of Paclitaxel Within The Nervous System Of The Rat After Repeated Intravenous Administration

    G Cavaletti;E Cavalletti;N Oggioni;C Sottani

  • Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

    Giovanni Germano;Roberta Frapolli;Matteo Simone;Michele Tavecchio

  • Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743

    Mario Minuzzo;Sergio Marchini;Massimo Broggini;Glynn Faircloth

  • microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition

    Aditya Parikh;Christine Lee;Peronne Joseph;Sergio Marchini

  • Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect

    Erica Salvati;Carlo Leonetti;Angela Rizzo;Marco Scarsella

  • α1 Acid Glycoprotein Binds to Imatinib (STI571) and Substantially Alters Its Pharmacokinetics in Chronic Myeloid Leukemia Patients

    Carlo Gambacorti-Passerini;Massimo Zucchetti;Domenico Russo;Roberta Frapolli

  • Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.

    M D’Incalci;N Badri;C M Galmarini;P Allavena

  • Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway.

    Angela Rizzo;Erica Salvati;Manuela Porru;Carmen D’Angelo

  • Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections

    Sergio Marchini;Duccio Cavalieri;Robert Fruscio;Enrica Calura

  • Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways.

    Giovanna Damia;Simonetta Silvestri;Laura Carrassa;Laura Filiberti

Frequent Co-Authors

Raffaella Giavazzi
Raffaella Giavazzi Mario Negri Institute for Pharmacological Research
Paolo G. Casali
Paolo G. Casali University of Milan
Chiara Romualdi
Chiara Romualdi University of Padua
Silvana Pilotti
Silvana Pilotti University of Milan
Paola Allavena
Paola Allavena Humanitas University
Alessandro Gronchi
Alessandro Gronchi University of Milan
Nicoletta Colombo
Nicoletta Colombo University of Milano-Bicocca
Silvio Garattini
Silvio Garattini Mario Negri Institute for Pharmacological Research
Valter Torri
Valter Torri Mario Negri Institute for Pharmacological Research
Gabriella Zupi
Gabriella Zupi École Normale Supérieure de Lyon

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical or healthcare career in the USA, there are a variety of alternative online pathways that can help you achieve your goals. Many students opt for online nursing doctoral programs, which offer flexibility for working professionals and can open doors to leadership roles in healthcare.

For registered nurses looking to further their education, the average cost of rn to bsn programs is an important consideration. Finding affordable and accredited programs is key for advancing your career without accumulating significant debt.

Those with non-nursing backgrounds who wish to become advanced practice nurses can explore non nursing bachelor's to msn online options. These accelerated degrees allow you to fast-track your entry into nursing.

Additionally, if you want to start with a bachelor’s in nursing, looking into the easiest bsn program to get into can help you identify accessible programs that fit your academic history and future plans.

Best Scientists Citing Maurizio D'Incalci

Trending Scientists

Recently Published Articles